| 02/13/2026 5:04 AM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/06/2026 2:00 PM | Bright Minds Biosciences (1827401) Subject Cormorant Asset Management, LP (1583977) Filed by | Form SCHEDULE 13G/A | |
| 01/09/2026 3:11 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/08/2026 6:32 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/07/2026 8:37 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/07/2026 4:27 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/07/2026 2:16 PM | Bright Minds Biosciences (1827401) Subject | Form FWP | |
| 01/06/2026 8:54 PM | Bright Minds Biosciences (1827401) Filer | Form 424B5 | |
| 01/06/2026 8:55 PM | Bright Minds Biosciences (1827401) Subject | Form FWP | |
| 01/06/2026 4:27 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/05/2026 4:25 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for DRUG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Bright Minds Biosciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 12/23/2025 4:26 PM | Bright Minds Biosciences (1827401) Filer | Form 40-F Registration statement pursuant to Section 12 or annual report pursuant to Section 13(a) or 15(d) | |
| 12/23/2025 4:27 PM | Bright Minds Biosciences (1827401) Subject | Form F-X Appointment of agent for service of process and undertaking | |
| 11/17/2025 4:11 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/17/2025 2:58 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K/A | |
| 11/14/2025 5:38 PM | Bright Minds Biosciences (1827401) Subject Vivo Opportunity Fund Holdings, L.P. (1930214) Filed by | Form SCHEDULE 13G | |
| 11/13/2025 8:00 AM | Adage Capital Management, L.P. (1535978) Filed by Bright Minds Biosciences (1827401) Subject | Form SCHEDULE 13G | |
| 11/12/2025 7:00 AM | Bright Minds Biosciences (1827401) Subject Sio Capital Management, LLC (1482416) Filed by | Form SCHEDULE 13G/A | |
| 11/07/2025 3:31 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/07/2025 3:16 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/02/2025 11:15 PM | Bright Minds Biosciences (1827401) Filer | Form EFFECT | |
| 08/14/2025 9:58 AM | Bright Minds Biosciences (1827401) Subject JANUS HENDERSON GROUP PLC (1274173) Filed by | Form SCHEDULE 13G/A | |
| 08/13/2025 1:00 PM | Bright Minds Biosciences (1827401) Subject Sio Capital Management, LLC (1482416) Filed by | Form SCHEDULE 13G/A | |
| 08/08/2025 8:36 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/28/2025 2:41 PM | Bright Minds Biosciences (1827401) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |